Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8131484.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case of severe cardiac failure due to iron overload in a patient with beta-thalassemia major is reported. The patient was successfully treated with high-dose ambulatory intravenous deferoxamine (desferrioxamine). This type of chelation appears to be a valuable alternative to subcutaneous deferoxamine administration in the presence of severe iron overload.
Medical subject headings
- Deferoxamine
- Heart Failure
- beta-Thalassemia